Blaze Bioscience, Inc.
Fluorescent imaging agents for real-time tumor visualization during cancer surgery
- Sector
- Biotech
- Headquarters
- SEATTLE, WA
- Founded
- 2010
- Latest Form D
- $25M, Oct 2024
- Total capital
- $101M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $98.9M
- 12 Form D · last Oct 2024
- 24 months since last filing
- Federal contracts
- $1.7M
- 2 awards · Health and Human S
- Rank in Biotech#146 of 4373
- Granted patents
- 8
- 32 pending · first 2021
- Rank in peer group#196 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 12th filing$25M
- Private capital raisedForm D · SEC · 11th filing$15M
- Private capital raisedForm D · SEC · 10th filing$10M
- Private capital raisedForm D · SEC · 9th filing$8.1M
- Private capital raisedForm D · SEC · 8th filing$5M
- Private capital raisedForm D · SEC · 7th filing$3M
- Private capital raisedForm D · SEC · 6th filing$16.1M
- Private capital raisedForm D · SEC · 5th filing$554K
- Private capital raisedForm D · SEC · 4th filing$991K
- Private capital raisedForm D · SEC · 3rd filing$8.1M
- Private capital raisedForm D · SEC · 2nd filing$6.4M
- Private capital raisedForm D · SEC · 1st filing$725K
Show 2 earlier federal awards
- Federal contractHealth and Human S · Igf::ot::igf A Novel Tumor Paint Product For Sarcoma Resection$1.5M
- Federal contractHealth and Human S · Igf::ot::igf Other Functions - A Novel Tumor Paint For Tumor Resection$249K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#196 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Claudia Koch JochheimExecutive OfficerNamed in SEC Form D filings
- Dennis Cameron MillerExecutive OfficerNamed in SEC Form D filings
- Heather L. FranklinDirectorNamed in SEC Form D filings
- James M. OlsonDirectorNamed in SEC Form D filings
- JAMES C. TOWNEDirectorNamed in SEC Form D filings
- Jan K. OhrstromDirectorNamed in SEC Form D filings
Show all 11 people
- Julia C. NovakExecutive OfficerNamed in SEC Form D filings
- Lawrence Patrick HughesDirectorNamed in SEC Form D filings
- Ludmila LobanovaExecutive OfficerNamed in SEC Form D filings
- Mary Ellen HughesDirectorNamed in SEC Form D filings
- Steven R. DalyExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 40- PendingEngineered Liquid Crystal Shutter As A Dynamic Long-pass Optical FilterUSPTOApplication 18992474
- PendingTransferrin Receptor Targeting Peptide Oligonucleotide Complexes And Methods Of Use ThereofUSPTOApplication 18683490
- PendingCompositions And Methods For Selective Depletion Of Target MoleculesUSPTOApplication 18037923
Show all 40 patent records
- Engineered Liquid Crystal Shutter As A Dynamic Long-pass Optical FilterJan 8, 2026 · Application 18992474Pending
- Transferrin Receptor Targeting Peptide Oligonucleotide Complexes And Methods Of Use ThereofOct 23, 2025 · Application 18683490Pending
- Compositions And Methods For Selective Depletion Of Target MoleculesJun 19, 2025 · Application 18037923Pending
- Chlorotoxin Conjugates And Methods Of Use ThereofApr 10, 2025 · Application 18618998Pending
- Tumor Homing And Cell Penetrating Peptide-immuno-oncology Agent Complexes And Methods Of Use ThereofSep 19, 2024 · Application 18518088Pending
- PD-L1 Binding Peptides And Peptide Complexes And Methods Of Use ThereofAug 29, 2024 · Application 18037926Pending
- Systems And Methods For Simultaneous Near-infrared Light And Visible Light ImagingAug 22, 2024 · Application 18012621Pending
- Methods Of Treating Breast CancerJul 30, 2024 · US 12,048,732Granted
- Tissue-homing Peptide Conjugates And Methods Of Use ThereofJul 30, 2024 · US 12,048,750Granted
- Tumor Homing And Cell Penetrating Peptide-immuno-oncology Agent Complexes And Methods Of Use ThereofJan 9, 2024 · US 11,866,466Granted
- Cartilage-homing PeptidesNov 16, 2023 · Application 18177642Pending
- Methods Of Treatment Using Chlorotoxin ConjugatesAug 17, 2023 · Application 18160954Pending
- Cartilage-homing PeptidesMay 16, 2023 · US 11,648,290Granted
- Methods Of Treating Vascular Lesions And MalformationsFeb 9, 2023 · Application 17764132Pending
- Tissue-homing Peptide Conjugates And Methods Of Use ThereofJan 24, 2023 · US 11,559,580Granted
- Systems And Methods For Vascular And Structural ImagingNov 3, 2022 · Application 17764131Pending
- Renal-homing Peptide Conjugates And Methods Of Use ThereofMay 17, 2022 · US 11,331,393Granted
- Cartilage-homing Peptide Conjugates And Methods Of Use ThereofAug 26, 2021 · Application 17230353Pending
- Cartilage-homing PeptidesAug 17, 2021 · US 11,090,358Granted
- Truncated Cartilage-homing Peptides And Peptide Complexes And Methods Of Use ThereofJun 10, 2021 · Application 16980787Pending
- Cartilage-homing Peptide Conjugates And Methods Of Use ThereofMay 25, 2021 · US 11,013,814Granted
- Systems And Methods For Simultaneous Near-infrared Light And Visible Light ImagingJan 21, 2021 · Application 17041675Pending
- Chlorotoxin Conjugates And Methods Of Use ThereofJun 18, 2020 · Application 16704955Pending
- Stable Peptides And Methods Of Use ThereofDec 12, 2019 · Application 16330069Pending
- Methods Of Treatment Using Chlorotoxin ConjugatesMay 30, 2019 · Application 16091692Pending
- Chlorotoxin Conjugates And Methods Of Use ThereofApr 7, 2016 · Application 14855355Pending
- Renal-homing Peptide Conjugates And Methods Of Use ThereofApplication PCTUS2018037544Pending
- Systems And Methods For Simultaneous Near-infrared Light And Visible Light ImagingApplication 62679671Pending
- Truncated Cartilage-homing Peptides And Peptide Conjugates And Methods Of Use ThereofApplication 62676033Pending
- Systems And Methods For Simultaneous Near-infrared Light And Visible Light ImagingApplication 62650974Pending
- Cartilage-homing Peptide Conjugates And Methods Of Use ThereofApplication PCTUS2018023006Pending
- Truncated Cartilage-homing Peptides And Peptide Conjugates And Methods Of Use ThereofApplication 62644329Pending
- Tumor Homing And Cell Penetrating Peptide-immuno-oncology Agent Complexes And Methods Of Use ThereofApplication 62622711Pending
- Tumor Homing And Cell Penetrating Peptide-immuno-oncology Agent Complexes And Methods Of Use ThereofApplication 62607893Pending
- Stable Peptides And Methods Of Use ThereofApplication PCTUS2017050855Pending
- Renal-homing Peptide Conjugates And Methods Of Use ThereofApplication 62520323Pending
- Methods Of Treating Breast CancerApplication PCTUS2017027812Pending
- Methods Of Treating Breast CancerApplication 62485830Pending
- Methods Of Treatment Using Chlorotoxin ConjugatesApplication PCTUS2017027276Pending
- Methods Of Treatment Using Chlorotoxin ConjugatesApplication 62484818Pending
Related companies, and why
- ABZYME THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.8M in contracts
- INTEGRATED RESEARCH ASSOCIATES, LLCSimilar federal contract value in Biotech · $1.8M in contracts
- LUCERNA INCSimilar federal contract value in Biotech · $1.8M in contracts
- ADJUVANCE TECHNOLOGIES INC.Similar federal contract value in Biotech · $1.7M in contracts
- INGENIOUS TARGETING LABORATORY INC.Similar federal contract value in Biotech · $1.7M in contracts
- SCRIBE BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.7M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .